Champions Oncology Inc reports results for the quarter ended in April - Earnings Summary

Champions Oncology

22/07/2021 15:38

* Champions Oncology Inc  CSBR.OQ  reported a quarterly adjusted
loss of 4 cents​​ per share for the quarter ended in April. The
mean expectation of three analysts for the quarter was
for breakeven results per share.
* Revenue rose 20.7% to $10.57 million from a year ago; 
analysts expected $10.03 million. 
* Champions Oncology Inc's reported EPS for the quarter was a
loss of 4 cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Champions Oncology Inc shares had fallen by 1.8% this
quarter and lost 6.5% so far this year.
* The company reported a quarterly loss of $481 thousand.
* Wall Street's median 12-month price target for Champions
Oncology Inc is $15.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated July 22 at 02:38 p.m.  ​All
figures in US dollars unless otherwise stated